The role of adjuvant probiotics to attenuate intestinal inflammatory responses due to cancer treatments
In: Beneficial MicrobesSearch for other papers by M. Thomsen in
Current site
Google Scholar
Northern Clinical School, Kolling Institute of Medical Research, Pacific Hwy, St Leonards NSW 2065, Australia.
Search for other papers by S. Clarke in
Current site
Google Scholar
Medlab Clinical Ltd., 66 McCauley St., Sydney, 2006 NSW, Australia.
Search for other papers by L. Vitetta in
Current site
Google Scholar
Chemotherapy and radiotherapy treatment regimens for gastrointestinal, peritoneal and pelvic tumours can disrupt the intestinal microbiome and intestinal epithelia. Such disturbances can provoke symptoms such as diarrhoea, nausea and vomiting. Chemotherapy and radiotherapy induced gastrointestinal toxicity aggravating intestinal microbiome dysbiosis is postulated to adversely alter the intestinal microbiome, with a consequent induced pro-inflammatory effect that disrupts the intestinal microbiome-epithelia-mucosal immunity axis. Although not widely recognised, the intestinal mucosa is the largest and most densely and dynamically populated immune-environment. Cancer treatment adverse effects that affect intestinal and mucosal cells inadvertently target and disrupt resident intestinal macrophages, the cells that marshal immune activity in the intestinal mucosa by shaping pro-inflammatory and anti-inflammatory activities to control and eradicate infectious insults and maintain local homeostasis. Pathobionts (bacteria capable of pathogenic pro-inflammatory activity) and noxious environmental and bacterial antigens use the intestinal epithelia and gap junctions as a point of entry into the systemic circulation. This translocation movement promotes toxic sequelae that obstruct intestinal macrophage functions resulting in uncontrolled local and systemic pro-inflammatory activity, loss of phagocytic function and loss of expression of tight junction proteins. Probiotic bacteria as an adjunctive treatment shows efficacy in ameliorating enteropathies such as mucositis/diarrhoea resulting from chemotherapy or radiotherapy regimens. As such we posit that an important benefit that warrants a further focused research effort is the administration of adjuvant probiotics to help reduce the incidence of febrile neutropenia.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
-
Alexander, J.L., Wilson, I.D., Teare, J., Marchesi, J.R., Nicholson, J.K. and Kinross, J.M., 2017. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nature Reviews Gastroenterology and Hepatology 14: 356-365.
'Gut microbiota modulation of chemotherapy efficacy and toxicity ' () 14 Nature Reviews Gastroenterology and Hepatology : 356 -365.
-
Ambalam, P., Raman, M., Purama, R.K. and Doble, M., 2016. Probiotics, prebiotics and colorectal cancer prevention. Best Practice & Research: Clinical Gastroenterology 30: 119-131.
'Probiotics, prebiotics and colorectal cancer prevention ' () 30 Best Practice & Research: Clinical Gastroenterology : 119 -131.
-
Amitay, E.L., Werner, S., Vital, M., Pieper, D.H., Hofler, D., Gierse, I.J., Butt, J., Balavarca, Y., Cuk, K. and Brenner, H., 2017. Fusobacterium and colorectal cancer: causal factor or passenger? Results from a large colorectal cancer screening study. Carcinogenesis 38: 781-788.
'Fusobacterium and colorectal cancer: causal factor or passenger? ' () 38 Carcinogenesis : 781 -788.
-
Andreyev, J., Ross, P., Donnellan, C., Lennan, E., Leonard, P., Waters, C., Wedlake, L., Bridgewater, J., Glynne-Jones, R., Allum, W., Chau, I., Wilson, R. and Ferry, D., 2014. Guidance on the management of diarrhoea during cancer chemotherapy. The Lancet Oncology 15: e447-460.
'Guidance on the management of diarrhoea during cancer chemotherapy ' () 15 The Lancet Oncology : e447 -460.
-
Aprile, G., Rihawi, K., De Carlo, E. and Sonis, S.T., 2015. Treatment-related gastrointestinal toxicities and advanced colorectal or pancreatic cancer: a critical update. World Journal of Gastroenterology 21: 11793-11803.
'Treatment-related gastrointestinal toxicities and advanced colorectal or pancreatic cancer: a critical update ' () 21 World Journal of Gastroenterology : 11793 -11803.
-
Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., Kim, S., Fritz, J.V., Wilmes, P., Ueha, S., Matsushima, K., Ohno, H., Olle, B., Sakaguchi, S., Taniguchi, T., Morita, H., Hattori, M. and Honda, K., 2013. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500: 232-236.
'Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota ' () 500 Nature : 232 -236.
-
Avadhani, A. and Miley, H., 2011. Probiotics for prevention of antibiotic-associated diarrhea and Clostridium difficile-associated disease in hospitalized adults – a meta-analysis. Journal of the American Association of Nurse Practitioners 23: 269-274.
'Probiotics for prevention of antibiotic-associated diarrhea and Clostridium difficile-associated disease in hospitalized adults – a meta-analysis ' () 23 Journal of the American Association of Nurse Practitioners : 269 -274.
-
Bastos, R.W., Pedroso, S.H., Vieira, A.T., Moreira, L.M., Franca, C.S., Cartelle, C.T., Arantes, R.M., Generoso, S.V., Cardoso, V.N., Neves, M.J., Nicoli, J.R. and Martins, F.S., 2016. Saccharomyces cerevisiae UFMG A-905 treatment reduces intestinal damage in a murine model of irinotecan-induced mucositis. Beneficial Microbes 7: 549-557.
'Saccharomyces cerevisiae UFMG A-905 treatment reduces intestinal damage in a murine model of irinotecan-induced mucositis ' () 7 Beneficial Microbes : 549 -557.
-
Beutheu Youmba, S., Belmonte, L., Galas, L., Boukhettala, N., Bole-Feysot, C., Dechelotte, P. and Coeffier, M., 2012. Methotrexate modulates tight junctions through NF-kappaB, MEK, and JNK pathways. Journal of Pediatric Gastroenterology and Nutrition 54: 463-470.
'Methotrexate modulates tight junctions through NF-kappaB, MEK, and JNK pathways ' () 54 Journal of Pediatric Gastroenterology and Nutrition : 463 -470.
-
Brown, J., Wang, H., Hajishengallis, G.N. and Martin, M., 2011. TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. Journal of Dental Research 90: 417-427.
'TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk ' () 90 Journal of Dental Research : 417 -427.
-
Bullman, S., Pedamallu, C.S., Sicinska, E., Clancy, T.E., Zhang, X., Cai, D., Neuberg, D., Huang, K., Guevara, F., Nelson, T., Chipashvili, O., Hagan, T., Walker, M., Ramachandran, A., Diosdado, B., Serna, G., Mulet, N., Landolfi, S., Ramon, Y.C.S., Fasani, R., Aguirre, A.J., Ng, K., Elez, E., Ogino, S., Tabernero, J., Fuchs, C.S., Hahn, W.C., Nuciforo, P. and Meyerson, M., 2017. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 358: 1443-1448.
'Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer ' () 358 Science : 1443 -1448.
-
Bultman, S.J., 2014. Emerging roles of the microbiome in cancer. Carcinogenesis 35: 249-255.
'Emerging roles of the microbiome in cancer ' () 35 Carcinogenesis : 249 -255.
-
Caballero-Franco, C., Keller, K., De Simone, C. and Chadee, K., 2007. The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. American Journal of Physiology – Gastrointestinal and Liver Physiology 292: G315-322.
'The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells ' () 292 American Journal of Physiology – Gastrointestinal and Liver Physiology : G315 -322.
-
Cario, E., Gerken, G. and Podolsky, D.K., 2004. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127: 224-238.
'Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C ' () 127 Gastroenterology : 224 -238.
-
Castro, M.G., Sanchez, P.X., Glasberg, J., Horie, L.M. and Waitzberg, D.L., 2009. Effects of probiotic in prevention of radiation-induced diarrhea. Clinical Nutrition Supplement 4: 72-73.
'Effects of probiotic in prevention of radiation-induced diarrhea ' () 4 Clinical Nutrition Supplement : 72 -73.
-
Chitapanarux, I., Chitapanarux, T., Traisathit, P., Kudumpee, S., Tharavichitkul, E. and Lorvidhaya, V., 2010. Randomized controlled trial of live Lactobacillus acidophilus plus Bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiation Oncology 5: 31.
'Randomized controlled trial of live Lactobacillus acidophilus plus Bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients ' () 5 Radiation Oncology : 31.
-
Cornely, O.A., Maertens, J., Winston, D.J., Perfect, J., Ullmann, A.J., Walsh, T.J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y.T., Petrini, M., Hardalo, C., Suresh, R. and Angulo-Gonzalez, D., 2007. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. New England Journal of Medicine 356: 348-359.
'Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia ' () 356 New England Journal of Medicine : 348 -359.
-
Cremonini, F., Di Caro, S., Nista, E.C., Bartolozzi, F., Capelli, G., Gasbarrini, G. and Gasbarrini, A., 2002. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Alimentary Pharmacology and Therapeutics 16: 1461-1467.
'Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea ' () 16 Alimentary Pharmacology and Therapeutics : 1461 -1467.
-
D’Souza, A.L., Rajkumar, C., Cooke, J. and Bulpitt, C.J., 2002. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 324: 1361.
'Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis ' () 324 BMJ : 1361.
-
Delia, P., Sansotta, G., Donato, V., Frosina, P., Messina, G., De Renzis, C. and Famularo, G., 2007. Use of probiotics for prevention of radiation-induced diarrhea. World Journal of Gastroenterology 13: 912-915.
'Use of probiotics for prevention of radiation-induced diarrhea ' () 13 World Journal of Gastroenterology : 912 -915.
-
Delia, P., Sansotta, G., Donato, V., Messina, G., Frosina, P., Pergolizzi, S., De Renzis, C. and Famularo, G., 2002. Prevention of radiation-induced diarrhea with the use of VSL#3, a new high-potency probiotic preparation. American Journal of Gastroenterology 97: 2150-2152.
'Prevention of radiation-induced diarrhea with the use of VSL#3, a new high-potency probiotic preparation ' () 97 American Journal of Gastroenterology : 2150 -2152.
-
Demers, M., Dagnault, A. and Desjardins, J., 2014. A randomized double-blind controlled trial: impact of probiotics on diarrhea in patients treated with pelvic radiation. Clinical Nutrition 33: 761-767.
'A randomized double-blind controlled trial: impact of probiotics on diarrhea in patients treated with pelvic radiation ' () 33 Clinical Nutrition : 761 -767.
-
DeVita Jr., V.T., Young, R.C. and Canellos, G.P., 1975. Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer. Cancer 35: 98-110.
'Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer ' () 35 Cancer : 98 -110.
-
Doron, S. and Snydman, D.R., 2015. Risk and safety of probiotics. Clinical Infectious Diseases 60, Suppl. 2: S129-134.
'Risk and safety of probiotics ' () 2 Clinical Infectious Diseases : S129 -134.
-
Ewaschuk, J.B., Diaz, H., Meddings, L., Diederichs, B., Dmytrash, A., Backer, J., Looijer-Van Langen, M. and Madsen, K.L., 2008. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. American Journal of Physiology – Gastrointestinal and Liver Physiology 295: G1025-G1034.
'Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function ' () 295 American Journal of Physiology – Gastrointestinal and Liver Physiology : G1025 -G1034.
-
Fasano, A., 2011. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiological Reviews 91: 151-175.
'Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer ' () 91 Physiological Reviews : 151 -175.
-
Fasano, A., 2012. Zonulin, regulation of tight junctions, and autoimmune diseases. Annals of the New York Academy of Science 1258: 25-33.
'Zonulin, regulation of tight junctions, and autoimmune diseases ' () 1258 Annals of the New York Academy of Science : 25 -33.
-
Fijlstra, M., Ferdous, M., Koning, A.M., Rings, E.H., Harmsen, H.J. and Tissing, W.J., 2015. Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model. Support Care Cancer 23: 1513-1522.
'Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model ' () 23 Support Care Cancer : 1513 -1522.
-
Forsgård, R.A., Korpela, R., Holma, R., Linden, J., Frias, R., Spillmann, T. and Osterlund, P., 2016. Intestinal permeability to iohexol as an in vivo marker of chemotherapy-induced gastrointestinal toxicity in Sprague-Dawley rats. Cancer Chemotherapy and Pharmacology 78: 863-874.
'Intestinal permeability to iohexol as an in vivo marker of chemotherapy-induced gastrointestinal toxicity in Sprague-Dawley rats ' () 78 Cancer Chemotherapy and Pharmacology : 863 -874.
-
Frankel, A.E., Froehlich, T.W., Kim, J., Coughlin, Y.X., Frenkel, E.P. and Koh, A.Y., 2017. Metagenomic shotgun sequencing to identify specific human gut microbes associated with immune checkpoint therapy efficacy in melanoma patients. Journal of Clinical Oncology 35(15): 9516-9516.
'Metagenomic shotgun sequencing to identify specific human gut microbes associated with immune checkpoint therapy efficacy in melanoma patients ' () 35 Journal of Clinical Oncology : 9516 -9516.
-
Gagnière, J., Raisch, J., Veziant, J., Barnich, N., Bonnet, R., Buc, E., Bringer, M.A., Pezet, D. and Bonnet, M., 2016. Gut microbiota imbalance and colorectal cancer. World Journal of Gastroenterology 22: 501-518.
'Gut microbiota imbalance and colorectal cancer ' () 22 World Journal of Gastroenterology : 501 -518.
-
Galloway-Peña, J., 2015. Abstract B993. Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC). American Society for Microbiology.
'Abstract B993 ', in Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) , ().
-
Garcia-Peris, P., Velasco, C., Lozano, M.A., Moreno, Y., Paron, L., De la Cuerda, C., Breton, I., Camblor, M., Garcia-Hernandez, J., Guarner, F. and Hernandez, M., 2012. Effect of a mixture of inulin and fructo-oligosaccharide on Lactobacillus and Bifidobacterium intestinal microbiota of patients receiving radiotherapy: a randomised, double-blind, placebo-controlled trial. Nutrición Hospitalaria 27: 1908-1915.
'Effect of a mixture of inulin and fructo-oligosaccharide on Lactobacillus and Bifidobacterium intestinal microbiota of patients receiving radiotherapy: a randomised, double-blind, placebo-controlled trial ' () 27 Nutrición Hospitalaria : 1908 -1915.
-
Giralt, J., Regadera, J.P., Verges, R., Romero, J., De la Fuente, I., Biete, A., Villoria, J., Cobo, J.M. and Guarner, F., 2008. Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial. International Journal of Radiation Oncology 71: 1213-1219.
'Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial ' () 71 International Journal of Radiation Oncology : 1213 -1219.
-
Gopalakrishnan, V., Spencer, C.N., Nezi, L., Reuben, A., Andrews, M.C., Karpinets, T.V., Prieto, P.A., Vicente, D., Hoffman, K., Wei, S.C., Cogdill, A.P., Zhao, L., Hudgens, C.W., Hutchinson, D.S., Manzo, T., Petaccia de Macedo, M., Cotechini, T., Kumar, T., Chen, W.S., Reddy, S.M., Sloane, R.S., Galloway-Pena, J., Jiang, H., Chen, P.L., Shpall, E.J., Rezvani, K., Alousi, A.M., Chemaly, R.F., Shelburne, S., Vence, L.M., Okhuysen, P.C., Jensen, V.B., Swennes, A.G., McAllister, F., Sanchez, E.M.R., Zhang, Y., Le Chatelier, E., Zitvogel, L., Pons, N., Austin-Breneman, J.L., Haydu, L.E., Burton, E.M., Gardner, J.M., Sirmans, E., Hu, J., Lazar, A.J., Tsujikawa, T., Diab, A., Tawbi, H., Glitza, I.C., Hwu, W.J., Patel, S.P., Woodman, S.E., Amaria, R.N., Davies, M.A., Gershenwald, J.E., Hwu, P., Lee, J.E., Zhang, J., Coussens, L.M., Cooper, Z.A., Futreal, P.A., Daniel, C.R., Ajami, N.J., Petrosino, J.F., Tetzlaff, M.T., Sharma, P., Allison, J.P., Jenq, R.R. and Wargo, J.A., 2017. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science: eaan4236.
'Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients ', in Science , () eaan4236.
-
Gopalakrishnan, V., Spencer, C.N., Nezi, L., Reuben, A., Andrews, M.C., Karpinets, T.V., Prieto, P.A., Vicente, D., Hoffman, K., Wei, S.C., Cogdill, A.P., Zhao, L., Hudgens, C.W., Hutchinson, D.S., Manzo, T., Petaccia de Macedo, M., Cotechini, T., Kumar, T., Chen, W.S., Reddy, S.M., Szczepaniak Sloane, R., Galloway-Pena, J., Jiang, H., Chen, P.L., Shpall, E.J., Rezvani, K., Alousi, A.M., Chemaly, R.F., Shelburne, S., Vence, L.M., Okhuysen, P.C., Jensen, V.B., Swennes, A.G., McAllister, F., Marcelo Riquelme Sanchez, E., Zhang, Y., Le Chatelier, E., Zitvogel, L., Pons, N., Austin-Breneman, J.L., Haydu, L.E., Burton, E.M., Gardner, J.M., Sirmans, E., Hu, J., Lazar, A.J., Tsujikawa, T., Diab, A., Tawbi, H., Glitza, I.C., Hwu, W.J., Patel, S.P., Woodman, S.E., Amaria, R.N., Davies, M.A., Gershenwald, J.E., Hwu, P., Lee, J.E., Zhang, J., Coussens, L.M., Cooper, Z.A., Futreal, P.A., Daniel, C.R., Ajami, N.J., Petrosino, J.F., Tetzlaff, M.T., Sharma, P., Allison, J.P., Jenq, R.R. and Wargo, J.A., 2018. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359: 97-103.
'Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients ' () 359 Science : 97 -103.
-
Gottschalk, C. and Kurts, C., 2015. The debate about dendritic cells and macrophages in the kidney. Frontiers in Immunology 6: 435.
'The debate about dendritic cells and macrophages in the kidney ' () 6 Frontiers in Immunology : 435.
-
Grabenbauer, G.G. and Holger, G., 2016. Management of radiation and chemotherapy related acute toxicity in gastrointestinal cancer. Best Practice & Research: Clinical Gastroenterology 30: 655-664.
'Management of radiation and chemotherapy related acute toxicity in gastrointestinal cancer ' () 30 Best Practice & Research: Clinical Gastroenterology : 655 -664.
-
Guilliams, M., Ginhoux, F., Jakubzick, C., Naik, S.H., Onai, N., Schraml, B.U., Segura, E., Tussiwand, R. and Yona, S., 2014. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nature Reviews Immunology 14: 571-578.
'Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny ' () 14 Nature Reviews Immunology : 571 -578.
-
Hamer, H.M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F.J. and Brummer, R.J., 2008. Review article: the role of butyrate on colonic function. Alimentary Pharmacology and Therapeutics 27: 104-119.
'Review article: the role of butyrate on colonic function ' () 27 Alimentary Pharmacology and Therapeutics : 104 -119.
-
Han, S.Y., Huh, C.S., Ahn, Y.T., Lim, K.S., Baek, Y.J. and Kim, D.H., 2005. Hepatoprotective effect of lactic acid bacteria, inhibitors of beta-glucuronidase production against intestinal microflora. Archives of Pharmacal Research 28: 325-329.
'Hepatoprotective effect of lactic acid bacteria, inhibitors of beta-glucuronidase production against intestinal microflora ' () 28 Archives of Pharmacal Research : 325 -329.
-
Henriksson, R., Franzen, L., Sandstrom, K., Nordin, A., Arevarn, M. and Grahn, E., 1995. Effects of active addition of bacterial cultures in fermented milk to patients with chronic bowel discomfort following irradiation. Supportive Care in Cancer 3: 81-83.
'Effects of active addition of bacterial cultures in fermented milk to patients with chronic bowel discomfort following irradiation ' () 3 Supportive Care in Cancer : 81 -83.
-
Hume, D.A., 2008. Macrophages as APC and the dendritic cell myth. Journal of Immunology 181: 5829-5835.
'Macrophages as APC and the dendritic cell myth ' () 181 Journal of Immunology : 5829 -5835.
-
Hussan, H., Clinton, S.K., Roberts, K. and Bailey, M.T., 2017. Fusobacterium’s link to colorectal neoplasia sequenced: a systematic review and future insights. World Journal of Gastroenterology 23: 8626-8650.
'Fusobacterium’s link to colorectal neoplasia sequenced: a systematic review and future insights ' () 23 World Journal of Gastroenterology : 8626 -8650.
-
Iida, N., Dzutsev, A., Stewart, C.A., Smith, L., Bouladoux, N., Weingarten, R.A., Molina, D.A., Salcedo, R., Back, T., Cramer, S., Dai, R.M., Kiu, H., Cardone, M., Naik, S., Patri, A.K., Wang, E., Marincola, F.M., Frank, K.M., Belkaid, Y., Trinchieri, G. and Goldszmid, R.S., 2013. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342: 967-970.
'Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment ' () 342 Science : 967 -970.
-
Justino, P.F., Melo, L.F., Nogueira, A.F., Morais, C.M., Mendes, W.O., Franco, A.X., Souza, E.P., Ribeiro, R.A., Souza, M.H. and Soares, P.M., 2015. Regulatory role of Lactobacillus acidophilus on inflammation and gastric dysmotility in intestinal mucositis induced by 5-fluorouracil in mice. Cancer Chemotherapy and Pharmacology 75: 559-567.
'Regulatory role of Lactobacillus acidophilus on inflammation and gastric dysmotility in intestinal mucositis induced by 5-fluorouracil in mice ' () 75 Cancer Chemotherapy and Pharmacology : 559 -567.
-
Kayama, H., Ueda, Y., Sawa, Y., Jeon, S.G., Ma, J.S., Okumura, R., Kubo, A., Ishii, M., Okazaki, T., Murakami, M., Yamamoto, M., Yagita, H. and Takeda, K., 2012. Intestinal CX3C chemokine receptor 1(high) (CX3CR1(high)) myeloid cells prevent T-cell-dependent colitis. Proceedings of the National Academy of Sciences of the USA 109: 5010-5015.
'Intestinal CX3C chemokine receptor 1(high) (CX3CR1(high)) myeloid cells prevent T-cell-dependent colitis ' () 109 Proceedings of the National Academy of Sciences of the USA : 5010 -5015.
-
Keefe, D.M., Cummins, A.G., Dale, B.M., Kotasek, D., Robb, T.A. and Sage, R.E., 1997. Effect of high-dose chemotherapy on intestinal permeability in humans. Clinical Science 92: 385-389.
'Effect of high-dose chemotherapy on intestinal permeability in humans ' () 92 Clinical Science : 385 -389.
-
Kim, Y., Kim, S.H., Whang, K.Y., Kim, Y.J. and Oh, S., 2008. Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells. Journal of Microbiology and Biotechnology 18: 1278-1285.
'Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells ' () 18 Journal of Microbiology and Biotechnology : 1278 -1285.
-
Koyama, S., Fujita, H., Shimosato, T., Kamijo, A., Ishiyama, Y., Yamamoto, E., Ishii, Y., Hattori, Y., Hagihara, M., Yamazaki, E., Tomita, N., Nakajima, H. and Yokohama Cooperative Study Group for Hematology, in press. Septicemia from Lactobacillus rhamnosus GG, from a probiotic enriched yogurt, in a patient with autologous stem cell transplantation. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-018-9399-6.
-
Kurita, A., Kado, S., Matsumoto, T., Asakawa, N., Kaneda, N., Kato, I., Uchida, K., Onoue, M. and Yokokura, T., 2011. Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of beta-glucuronidase activity in intestinal lumen. Cancer Chemotherapy and Pharmacology 67: 201-213.
'Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of beta-glucuronidase activity in intestinal lumen ' () 67 Cancer Chemotherapy and Pharmacology : 201 -213.
-
Ladas, E.J., Bhatia, M., Chen, L., Sandler, E., Petrovic, A., Berman, D.M., Hamblin, F., Gates, M., Hawks, R., Sung, L. and Nieder, M., 2016. The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation. Bone Marrow Transplant 51: 262-266.
'The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation ' () 51 Bone Marrow Transplant : 262 -266.
-
Lalla, R.V., Bowen, J., Barasch, A., Elting, L., Epstein, J., Keefe, D.M., McGuire, D.B., Migliorati, C., Nicolatou-Galitis, O., Peterson, D.E., Raber-Durlacher, J.E., Sonis, S.T. and Elad, S., 2014. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 120: 1453-1461.
'MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy ' () 120 Cancer : 1453 -1461.
-
Lee, J.Y., Chu, S.H., Jeon, J.Y., Lee, M.K., Park, J.H., Lee, D.C., Lee, J.W. and Kim, N.K., 2014. Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: a double-blind, randomized, placebo-controlled trial. Digestive and Liver Disease 46: 1126-1132.
'Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: a double-blind, randomized, placebo-controlled trial ' () 46 Digestive and Liver Disease : 1126 -1132.
-
Li, J., Sung, C.Y., Lee, N., Ni, Y., Pihlajamaki, J., Panagiotou, G. and El-Nezami, H., 2016. Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice. Proceedings of the National Academy of Sciences of the USA 113: E1306-E1315.
'Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice ' () 113 Proceedings of the National Academy of Sciences of the USA : E1306 -E1315.
-
Mack, D.R., Ahrne, S., Hyde, L., Wei, S. and Hollingsworth, M.A., 2003. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 52: 827-833.
'Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro ' () 52 Gut : 827 -833.
-
Mack, D.R., Michail, S., Wei, S., McDougall, L. and Hollingsworth, M.A., 1999. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. American Journal of Physiology 276: G941-950.
'Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression ' () 276 American Journal of Physiology : G941 -950.
-
Marchesi, J.R., Adams, D.H., Fava, F., Hermes, G.D., Hirschfield, G.M., Hold, G., Quraishi, M.N., Kinross, J., Smidt, H., Tuohy, K.M., Thomas, L.V., Zoetendal, E.G. and Hart, A., 2016. The gut microbiota and host health: a new clinical frontier. Gut 65: 330-339.
'The gut microbiota and host health: a new clinical frontier ' () 65 Gut : 330 -339.
-
Mego, M., Chovanec, J., Vochyanova-Andrezalova, I., Konkolovsky, P., Mikulova, M., Reckova, M., Miskovska, V., Bystricky, B., Beniak, J., Medvecova, L., Lagin, A., Svetlovska, D., Spanik, S., Zajac, V., Mardiak, J. and Drgona, L., 2015. Prevention of irinotecan induced diarrhea by probiotics: a randomized double blind, placebo controlled pilot study. Complementary Therapies in Medicine 23: 356-362.
'Prevention of irinotecan induced diarrhea by probiotics: a randomized double blind, placebo controlled pilot study ' () 23 Complementary Therapies in Medicine : 356 -362.
-
Mego, M., Ebringer, L., Drgona, L., Mardiak, J., Trupl, J., Greksak, R., Nemova, I., Oravcova, E., Zajac, V. and Koza, I., 2005. Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I. Neoplasma 52: 159-164.
'Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74 ' () 52 Neoplasma : 159 -164.
-
Mego, M., Holec, V., Drgona, L., Hainova, K., Ciernikova, S. and Zajac, V., 2013. Probiotic bacteria in cancer patients undergoing chemotherapy and radiation therapy. Complementary Therapies in Medicine 21: 712-723.
'Probiotic bacteria in cancer patients undergoing chemotherapy and radiation therapy ' () 21 Complementary Therapies in Medicine : 712 -723.
-
Mego, M., Koncekova, R., Mikuskova, E., Drgona, L., Ebringer, L., Demitrovicova, L., Nemova, I., Trupl, J., Mardiak, J., Koza, I. and Zajac, V., 2006. Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II study. Support Care Cancer 14: 285-290.
'Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74 ' () 14 Support Care Cancer : 285 -290.
-
Montassier, E., Gastinne, T., Vangay, P., Al-Ghalith, G.A., Bruley des Varannes, S., Massart, S., Moreau, P., Potel, G., De la Cochetiere, M.F., Batard, E. and Knights, D., 2015. Chemotherapy-driven dysbiosis in the intestinal microbiome. Alimentary Pharmacology and Therapeutics 42: 515-528.
'Chemotherapy-driven dysbiosis in the intestinal microbiome ' () 42 Alimentary Pharmacology and Therapeutics : 515 -528.
-
Nakao, T., Kurita, N., Komatsu, M., Yoshikawa, K., Iwata, T., Utusnomiya, T. and Shimada, M., 2012. Irinotecan injures tight junction and causes bacterial translocation in rat. Journal of Surgical Research 173: 341-347.
'Irinotecan injures tight junction and causes bacterial translocation in rat ' () 173 Journal of Surgical Research : 341 -347.
-
Ogino, H., Nakamura, K., Ihara, E., Akiho, H. and Takayanagi, R., 2011. CD4+CD25+ regulatory T cells suppress Th17-responses in an experimental colitis model. Digestive Diseases and Sciences 56: 376-386.
'CD4+CD25+ regulatory T cells suppress Th17-responses in an experimental colitis model ' () 56 Digestive Diseases and Sciences : 376 -386.
-
Okawa, T., Niibe, H., Arai, T., Sekiba, K., Noda, K., Takeuchi, S., Hashimoto, S. and Ogawa, N., 1993. Effect of LC9018 combined with radiation therapy on carcinoma of the uterine cervix. A phase III, multicenter, randomized, controlled study. Cancer 72: 1949-1954.
'Effect of LC9018 combined with radiation therapy on carcinoma of the uterine cervix ' () 72 Cancer : 1949 -1954.
-
Österlund, P., Ruotsalainen, T., Korpela, R., Saxelin, M., Ollus, A., Valta, P., Kouri, M., Elomaa, I. and Joensuu, H., 2007. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. British Journal of Cancer 97: 1028-1034.
'Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study ' () 97 British Journal of Cancer : 1028 -1034.
-
Peterson, L.W. and Artis, D., 2014. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nature Reviews Immunology 14: 141-153.
'Intestinal epithelial cells: regulators of barrier function and immune homeostasis ' () 14 Nature Reviews Immunology : 141 -153.
-
Purcell, R.V., Pearson, J., Aitchison, A., Dixon, L., Frizelle, F.A. and Keenan, J.I., 2017. Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia. PLoS ONE 12: e0171602.
'Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia ' () 12 PLoS ONE : e0171602.
-
Qin, H.L., Shen, T.Y., Gao, Z.G., Fan, X.B., Hang, X.M., Jiang, Y.Q. and Zhang, H.Z., 2005. Effect of lactobacillus on the gut microflora and barrier function of the rats with abdominal infection. World Journal of Gastroenterology 11: 2591-2596.
'Effect of lactobacillus on the gut microflora and barrier function of the rats with abdominal infection ' () 11 World Journal of Gastroenterology : 2591 -2596.
-
Raeessi, M.A., Raeessi, N., Panahi, Y., Gharaie, H., Davoudi, S.M., Saadat, A., Karimi Zarchi, A.A., Raeessi, F., Ahmadi, S.M. and Jalalian, H., 2014. ‘Coffee plus honey’ versus ‘topical steroid’ in the treatment of chemotherapy-induced oral mucositis: a randomised controlled trial. BMC Complementary and Alternative Medicine 14: 293.
'‘Coffee plus honey’ versus ‘topical steroid’ in the treatment of chemotherapy-induced oral mucositis: a randomised controlled trial ' () 14 BMC Complementary and Alternative Medicine : 293.
-
Rafter, J., Bennett, M., Caderni, G., Clune, Y., Hughes, R., Karlsson, P.C., Klinder, A., O’Riordan, M., O’Sullivan, G.C., Pool-Zobel, B., Rechkemmer, G., Roller, M., Rowland, I., Salvadori, M., Thijs, H., Van Loo, J., Watzl, B. and Collins, J.K., 2007. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. American Journal of Clinical Nutrition 85: 488-496.
'Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients ' () 85 American Journal of Clinical Nutrition : 488 -496.
-
Redman, M.G., Ward, E.J. and Phillips, R.S., 2014. The efficacy and safety of probiotics in people with cancer: a systematic review. Annals of Oncology 25: 1919-1929.
'The efficacy and safety of probiotics in people with cancer: a systematic review ' () 25 Annals of Oncology : 1919 -1929.
-
Resta-Lenert, S. and Barrett, K.E., 2003. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52: 988-997.
'Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC) ' () 52 Gut : 988 -997.
-
Ribeiro, R.A., Wanderley, C.W.S., Wong, D.V.T., Mota, J.M.S.C., Leite, C.A.V.G., Souza, M.H.L.P., Cunha, F.Q. and Lima-Junior, R.C.P., 2016. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives. Cancer Chemotherapy and Pharmacology 78: 881-893.
'Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives ' () 78 Cancer Chemotherapy and Pharmacology : 881 -893.
-
Robinson, K., Deng, Z., Hou, Y. and Zhang, G., 2015. Regulation of the intestinal barrier function by host defense peptides. Frontiers in Veterinary Science 2: 57.
'Regulation of the intestinal barrier function by host defense peptides ' () 2 Frontiers in Veterinary Science : 57.
-
Routy, B., Le Chatelier, E., Derosa, L., Duong, C.P.M., Alou, M.T., Daillere, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M.P., Fidelle, M., Flament, C., Poirier-Colame, V., Opolon, P., Klein, C., Iribarren, K., Mondragon, L., Jacquelot, N., Qu, B., Ferrere, G., Clemenson, C., Mezquita, L., Masip, J.R., Naltet, C., Brosseau, S., Kaderbhai, C., Richard, C., Rizvi, H., Levenez, F., Galleron, N., Quinquis, B., Pons, N., Ryffel, B., Minard-Colin, V., Gonin, P., Soria, J.C., Deutsch, E., Loriot, Y., Ghiringhelli, F., Zalcman, G., Goldwasser, F., Escudier, B., Hellmann, M.D., Eggermont, A., Raoult, D., Albiges, L., Kroemer, G. and Zitvogel, L., 2017. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359: 91-97.
'Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors ' () 359 Science : 91 -97.
-
Royo-Cebrecos, C., Gudiol, C., Ardanuy, C., Pomares, H., Calvo, M. and Carratala, J., 2017. A fresh look at polymicrobial bloodstream infection in cancer patients. PLoS ONE 12: e0185768.
'A fresh look at polymicrobial bloodstream infection in cancer patients ' () 12 PLoS ONE : e0185768.
-
Russo, F., Linsalata, M., Clemente, C., D’Attoma, B., Orlando, A., Campanella, G., Giotta, F. and Riezzo, G., 2013. The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study. BMC Cancer 13: 56.
'The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study ' () 13 BMC Cancer : 56.
-
Salminen, E., Elomaa, I., Minkkinen, J., Vapaatalo, H. and Salminen, S., 1988. Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clinical Radiology 39: 435-437.
'Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures ' () 39 Clinical Radiology : 435 -437.
-
Scartoni, D., Desideri, I., Giacomelli, I., Di Cataldo, V., Di Brina, L., Mancuso, A., Furfaro, I., Bonomo, P., Simontacchi, G. and Livi, L., 2015. Nutritional supplement based on zinc, prebiotics, probiotics and vitamins to prevent radiation-related gastrointestinal disorders. Anticancer Research 35: 5687-5692.
'Nutritional supplement based on zinc, prebiotics, probiotics and vitamins to prevent radiation-related gastrointestinal disorders ' () 35 Anticancer Research : 5687 -5692.
-
Schwabe, R.F. and Jobin, C., 2013. The microbiome and cancer. Nature Reviews Cancer 13: 800-812.
'The microbiome and cancer ' () 13 Nature Reviews Cancer : 800 -812.
-
Sharma, A., Chaudhary, S.P., Sreenivas, V., Prakash, S., Raina, V. and Shukla, N.K., 2013a. A phase II/III, randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic VSL#3, on chemotherapyinduced diarrhoea in cancer patients receiving fluoropyrimidines and or irinotecan (interim analysis). European Cancer Congress 2013. European Journal of Cancer, Elsevier Ltd, Amsterdam, the Netherlands.
'A phase II/III, randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic VSL#3, on chemotherapyinduced diarrhoea in cancer patients receiving fluoropyrimidines and or irinotecan (interim analysis) ', in European Cancer Congress 2013 , ().
-
Sharma, A., Chaudhary, S.P., Sreenivas, V., Prakash, S., Raina, V. and Shukla, N.K., 2013b. A phase II/III, randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic VSL#3, on chemotherapyinduced diarrhoea in cancer patients receiving fluoropyrimidines and or irinotecan (interim analysis). European Journal of Cancer 49: S273.
'A phase II/III, randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic VSL#3, on chemotherapyinduced diarrhoea in cancer patients receiving fluoropyrimidines and or irinotecan (interim analysis) ' () 49 European Journal of Cancer : S273.
-
Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly, Y.M., Glickman, J.N. and Garrett, W.S., 2013. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341: 569-573.
'The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis ' () 341 Science : 569 -573.
-
Smits, H.H., Engering, A., Van der Kleij, D., De Jong, E.C., Schipper, K., Van Capel, T.M., Zaat, B.A., Yazdanbakhsh, M., Wierenga, E.A., Van Kooyk, Y. and Kapsenberg, M.L., 2005. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. Journal of Allergy and Clinical Immunology 115: 1260-1267.
'Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin ' () 115 Journal of Allergy and Clinical Immunology : 1260 -1267.
-
Snydman, D.R., 2008. The safety of probiotics. Clinical Infectious Diseases 46, Suppl. 2: S104-S111.
'The safety of probiotics ' () 2 Clinical Infectious Diseases : S104 -S111.
-
Sommer, F., Anderson, J.M., Bharti, R., Raes, J. and Rosenstiel, P., 2017. The resilience of the intestinal microbiota influences health and disease. Nature Reviews Microbiology 15: 630-638.
'The resilience of the intestinal microbiota influences health and disease ' () 15 Nature Reviews Microbiology : 630 -638.
-
Sonis, S.T., 2004a. Oral mucositis in cancer therapy. Journal of Supportive Oncology 2: 3-8.
'Oral mucositis in cancer therapy ' () 2 Journal of Supportive Oncology : 3 -8.
-
Sonis, S.T., 2004b. The pathobiology of mucositis. Nature Reviews Cancer 4: 277-284.
'The pathobiology of mucositis ' () 4 Nature Reviews Cancer : 277 -284.
-
Sonis, S.T., Elting, L.S., Keefe, D., Peterson, D.E., Schubert, M., Hauer-Jensen, M., Bekele, B.N., Raber-Durlacher, J., Donnelly, J.P. and Rubenstein, E.B., 2004. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100: 1995-2025.
'Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients ' () 100 Cancer : 1995 -2025.
-
Spyropoulos, B.G., Theodoropoulos, G., Misiakos, E.P., Stoidis, C.N., Zapatis, H., Diamantopoulou, K., Gialeli, C., Karamanos, N.K., Karatzas, G., Machairas, A., Fotiadis, C., Zografos, G.C., Kelekis, N. and Kouloulias, V., 2013. The effect of synbiotics on acute radiation-induced diarrhea and its association with mucosal inflammatory and adaptive responses in rats. Digestive Diseases and Sciences 58: 2487-2498.
'The effect of synbiotics on acute radiation-induced diarrhea and its association with mucosal inflammatory and adaptive responses in rats ' () 58 Digestive Diseases and Sciences : 2487 -2498.
-
Stringer, A.M., Gibson, R.J., Bowen, J.M., Logan, R.M., Ashton, K., Yeoh, A.S., Al-Dasooqi, N. and Keefe, D.M., 2009. Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile. International Journal of Experimental Pathology 90: 489-499.
'Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile ' () 90 International Journal of Experimental Pathology : 489 -499.
-
Suzuki, H., Tani, K., Tamura, A., Tsukita, S. and Fujiyoshi, Y., 2015. Model for the architecture of claudin-based paracellular ion channels through tight junctions. Journal of Molecular Biology 427: 291-297.
'Model for the architecture of claudin-based paracellular ion channels through tight junctions ' () 427 Journal of Molecular Biology : 291 -297.
-
Szajewska, H. and Kolodziej, M., 2015. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Alimentary Pharmacology and Therapeutics 42: 793-801.
'Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea ' () 42 Alimentary Pharmacology and Therapeutics : 793 -801.
-
Teoh, F. and Pavelka, N., 2016. How chemotherapy increases the risk of systemic candidiasis in cancer patients: current paradigm and future directions. Pathogens 5: e6.
'How chemotherapy increases the risk of systemic candidiasis in cancer patients: current paradigm and future directions ' () 5 Pathogens : e6.
-
Theis, V.S., Sripadam, R., Ramani, V. and Lal, S., 2010. Chronic radiation enteritis. Clinical Oncology 22: 70-83.
'Chronic radiation enteritis ' () 22 Clinical Oncology : 70 -83.
-
Thomas, A.M., Jesus, E.C., Lopes, A., Aguiar Jr., S., Begnami, M.D., Rocha, R.M., Carpinetti, P.A., Camargo, A.A., Hoffmann, C., Freitas, H.C., Silva, I.T., Nunes, D.N., Setubal, J.C. and Dias-Neto, E., 2016. Tissue-associated bacterial alterations in rectal carcinoma patients revealed by 16S rRNA community profiling. Frontiers in Cellular and Infection Microbiology 6: 179.
'Tissue-associated bacterial alterations in rectal carcinoma patients revealed by 16S rRNA community profiling ' () 6 Frontiers in Cellular and Infection Microbiology : 179.
-
Thursky, K.A. and Worth, L.J., 2015. Can mortality of cancer patients with fever and neutropenia be improved? Current Opinion in Infectious Diseases 28: 505-513.
'Can mortality of cancer patients with fever and neutropenia be improved? ' () 28 Current Opinion in Infectious Diseases : 505 -513.
-
Timko, J., 2010. Probiotics as prevention of radiation-induced diarrhoea. Journal of Radiotherapy in Practice 9: 201-208.
'Probiotics as prevention of radiation-induced diarrhoea ' () 9 Journal of Radiotherapy in Practice : 201 -208.
-
Tjalsma, H., Boleij, A., Marchesi, J.R. and Dutilh, B.E., 2012. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nature Reviews Microbiology 10: 575-582.
'A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects ' () 10 Nature Reviews Microbiology : 575 -582.
-
Touchefeu, Y., Montassier, E., Nieman, K., Gastinne, T., Potel, G., Bruley des Varannes, S., Le Vacon, F. and De la Cochetiere, M.F., 2014. Systematic review: the role of the gut microbiota in chemotherapy-or radiation-induced gastrointestinal mucositis – current evidence and potential clinical applications. Alimentary Pharmacology and Therapeutics 40: 409-421.
'Systematic review: the role of the gut microbiota in chemotherapy-or radiation-induced gastrointestinal mucositis – current evidence and potential clinical applications ' () 40 Alimentary Pharmacology and Therapeutics : 409 -421.
-
Urbancsek, H., Kazar, T., Mezes, I. and Neumann, K., 2001. Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea. European Journal of Gastroenterology and Hepatology 13: 391-396.
'Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea ' () 13 European Journal of Gastroenterology and Hepatology : 391 -396.
-
Van der Velden, W.J., Herbers, A.H., Netea, M.G. and Blijlevens, N.M., 2014. Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis. British Journal of Haematology 167: 441-452.
'Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis ' () 167 British Journal of Haematology : 441 -452.
-
Van Vliet, M.J., Harmsen, H.J., De Bont, E.S. and Tissing, W.J., 2010. The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathogens 6: e1000879.
'The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis ' () 6 PLoS Pathogens : e1000879.
-
Viaud, S., Daillere, R., Boneca, I.G., Lepage, P., Langella, P., Chamaillard, M., Pittet, M.J., Ghiringhelli, F., Trinchieri, G., Goldszmid, R. and Zitvogel, L., 2015. Gut microbiome and anticancer immune response: really hot Sh*t! Cell Death and Differentiation 22: 199-214.
'Gut microbiome and anticancer immune response: really hot Sh*t! Cell Death and Differentiation ' () 22 : 199 -214.
-
Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillere, R., Hannani, D., Enot, D.P., Pfirschke, C., Engblom, C., Pittet, M.J., Schlitzer, A., Ginhoux, F., Apetoh, L., Chachaty, E., Woerther, P.L., Eberl, G., Berard, M., Ecobichon, C., Clermont, D., Bizet, C., Gaboriau-Routhiau, V., Cerf-Bensussan, N., Opolon, P., Yessaad, N., Vivier, E., Ryffel, B., Elson, C.O., Dore, J., Kroemer, G., Lepage, P., Boneca, I.G., Ghiringhelli, F. and Zitvogel, L., 2013. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342: 971-976.
'The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide ' () 342 Science : 971 -976.
-
Vitetta, L., Briskey, D., Alford, H., Hall, S. and Coulson, S., 2014a. Probiotics, prebiotics and the gastrointestinal tract in health and disease. Inflammopharmacology 22: 135-154.
'Probiotics, prebiotics and the gastrointestinal tract in health and disease ' () 22 Inflammopharmacology : 135 -154.
-
Vitetta, L., Manuel, R., Zhou, J.Y., Linnane, A.W., Hall, S. and Coulson, S., 2014b. The overarching influence of the gut microbiome on end-organ function: the role of live probiotic cultures. Pharmaceuticals 7: 954-989.
'The overarching influence of the gut microbiome on end-organ function: the role of live probiotic cultures ' () 7 Pharmaceuticals : 954 -989.
-
Wada, M., Nagata, S., Saito, M., Shimizu, T., Yamashiro, Y., Matsuki, T., Asahara, T. and Nomoto, K., 2010. Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies. Support Care Cancer 18: 751-759.
'Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies ' () 18 Support Care Cancer : 751 -759.
-
Wang, Y.H., Yao, N., Wei, K.K., Jiang, L., Hanif, S., Wang, Z.X. and Pei, C.X., 2016. The efficacy and safety of probiotics for prevention of chemoradiotherapy-induced diarrhea in people with abdominal and pelvic cancer: a systematic review and meta-analysis. European Journal of Clinical Nutrition 70: 1246-1253.
'The efficacy and safety of probiotics for prevention of chemoradiotherapy-induced diarrhea in people with abdominal and pelvic cancer: a systematic review and meta-analysis ' () 70 European Journal of Clinical Nutrition : 1246 -1253.
-
Wardill, H.R., Logan, R.M., Bowen, J.M., Van Sebille, Y.Z. and Gibson, R.J., 2016. Tight junction defects are seen in the buccal mucosa of patients receiving standard dose chemotherapy for cancer. Support Care Cancer 24: 1779-1788.
'Tight junction defects are seen in the buccal mucosa of patients receiving standard dose chemotherapy for cancer ' () 24 Support Care Cancer : 1779 -1788.
-
Wargo, J.A., Gopalakrishnan, V., Spencer, C., Karpinets, A.R., Andews, M.C. and Tetzlaff, M.T., 2017. Association of the diversity and composition of the gut microbiome with responses and survival (PFS) in metastatic melanoma (MM) patients (pts) on anti-PD-1 therapy. Journal of Clinical Oncology 35: 3008.
'Association of the diversity and composition of the gut microbiome with responses and survival (PFS) in metastatic melanoma (MM) patients (pts) on anti-PD-1 therapy ' () 35 Journal of Clinical Oncology : 3008.
-
Wei, Z., Tan, B., Cao, S., Liu, S., Tan, X., Yao, Z., Yin, N., Li, J., Zhang, D. and Zhou, Y., 2017. The influence of neoadjuvant chemotherapy on gastric cancer patients’ postoperative infectious complications: what is the negative role played by the intestinal barrier dysfunction? Oncotarget 8: 43376-43388.
'The influence of neoadjuvant chemotherapy on gastric cancer patients’ postoperative infectious complications: what is the negative role played by the intestinal barrier dysfunction? ' () 8 Oncotarget : 43376 -43388.
-
Williams, J.M., Duckworth, C.A., Watson, A.J., Frey, M.R., Miguel, J.C., Burkitt, M.D., Sutton, R., Hughes, K.R., Hall, L.J., Caamano, J.H., Campbell, B.J. and Pritchard, D.M., 2013. A mouse model of pathological small intestinal epithelial cell apoptosis and shedding induced by systemic administration of lipopolysaccharide. Disease Models and Mechanisms 6: 1388-1399.
'A mouse model of pathological small intestinal epithelial cell apoptosis and shedding induced by systemic administration of lipopolysaccharide ' () 6 Disease Models and Mechanisms : 1388 -1399.
-
Wong, H., Tang, Y.F., Yao, T.J., Chiu, J., Leung, R., Chan, P., Cheung, T.T., Chan, A.C., Pang, R.W., Poon, R., Fan, S.T. and Yau, T., 2011. The outcomes and safety of single-agent sorafenib in the treatment of elderly patients with advanced hepatocellular carcinoma (HCC). Oncologist 16: 1721-1728.
'The outcomes and safety of single-agent sorafenib in the treatment of elderly patients with advanced hepatocellular carcinoma (HCC) ' () 16 Oncologist : 1721 -1728.
-
Yamashiro, Y. and Nagata, S., 2010. Beneficial microbes for premature infants, and children with malignancy undergoing chemotherapy. Beneficial Microbes 1: 357-365.
'Beneficial microbes for premature infants, and children with malignancy undergoing chemotherapy ' () 1 Beneficial Microbes : 357 -365.
-
Zhan, Y., Chen, P.J., Sadler, W.D., Wang, F., Poe, S., Nunez, G., Eaton, K.A. and Chen, G.Y., 2013. Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury. Cancer Research 73: 7199-7210.
'Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury ' () 73 Cancer Research : 7199 -7210.
-
Zheng, S.G., 2013. Regulatory T cells vs Th17: differentiation of Th17 versus Treg, are the mutually exclusive? American Journal of Clinical and Experimental Immunology 2: 94-106.
'Regulatory T cells vs Th17: differentiation of Th17 versus Treg, are the mutually exclusive? ' () 2 American Journal of Clinical and Experimental Immunology : 94 -106.
-
Zitvogel, L., Galluzzi, L., Viaud, S., Vetizou, M., Daillere, R., Merad, M. and Kroemer, G., 2015. Cancer and the gut microbiota: an unexpected link. Science Translational Medicine 7: 271.
'Cancer and the gut microbiota: an unexpected link ' () 7 Science Translational Medicine : 271.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 830 | 210 | 24 |
| Full Text Views | 29 | 10 | 5 |
| PDF Views & Downloads | 53 | 18 | 11 |
The role of adjuvant probiotics to attenuate intestinal inflammatory responses due to cancer treatments
In: Beneficial MicrobesSearch for other papers by M. Thomsen in
Current site
Google Scholar
PubMed
Northern Clinical School, Kolling Institute of Medical Research, Pacific Hwy, St Leonards NSW 2065, Australia.
Search for other papers by S. Clarke in
Current site
Google Scholar
PubMed
Medlab Clinical Ltd., 66 McCauley St., Sydney, 2006 NSW, Australia.
Search for other papers by L. Vitetta in
Current site
Google Scholar
PubMed
Chemotherapy and radiotherapy treatment regimens for gastrointestinal, peritoneal and pelvic tumours can disrupt the intestinal microbiome and intestinal epithelia. Such disturbances can provoke symptoms such as diarrhoea, nausea and vomiting. Chemotherapy and radiotherapy induced gastrointestinal toxicity aggravating intestinal microbiome dysbiosis is postulated to adversely alter the intestinal microbiome, with a consequent induced pro-inflammatory effect that disrupts the intestinal microbiome-epithelia-mucosal immunity axis. Although not widely recognised, the intestinal mucosa is the largest and most densely and dynamically populated immune-environment. Cancer treatment adverse effects that affect intestinal and mucosal cells inadvertently target and disrupt resident intestinal macrophages, the cells that marshal immune activity in the intestinal mucosa by shaping pro-inflammatory and anti-inflammatory activities to control and eradicate infectious insults and maintain local homeostasis. Pathobionts (bacteria capable of pathogenic pro-inflammatory activity) and noxious environmental and bacterial antigens use the intestinal epithelia and gap junctions as a point of entry into the systemic circulation. This translocation movement promotes toxic sequelae that obstruct intestinal macrophage functions resulting in uncontrolled local and systemic pro-inflammatory activity, loss of phagocytic function and loss of expression of tight junction proteins. Probiotic bacteria as an adjunctive treatment shows efficacy in ameliorating enteropathies such as mucositis/diarrhoea resulting from chemotherapy or radiotherapy regimens. As such we posit that an important benefit that warrants a further focused research effort is the administration of adjuvant probiotics to help reduce the incidence of febrile neutropenia.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 830 | 210 | 24 |
| Full Text Views | 29 | 10 | 5 |
| PDF Views & Downloads | 53 | 18 | 11 |
